These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 21764099)

  • 1. Fate of antibiotics in activated sludge followed by ultrafiltration (CAS-UF) and in a membrane bioreactor (MBR).
    Sahar E; Messalem R; Cikurel H; Aharoni A; Brenner A; Godehardt M; Jekel M; Ernst M
    Water Res; 2011 Oct; 45(16):4827-36. PubMed ID: 21764099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of two treatments for the removal of selected organic micropollutants and bulk organic matter: conventional activated sludge followed by ultrafiltration versus membrane bioreactor.
    Sahar E; Ernst M; Godehardt M; Hein A; Herr J; Kazner C; Melin T; Cikurel H; Aharoni A; Messalem R; Brenner A; Jekel M
    Water Sci Technol; 2011; 63(4):733-40. PubMed ID: 21330721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fate and distribution of pharmaceuticals in wastewater and sewage sludge of the conventional activated sludge (CAS) and advanced membrane bioreactor (MBR) treatment.
    Radjenović J; Petrović M; Barceló D
    Water Res; 2009 Feb; 43(3):831-41. PubMed ID: 19091371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Membranebioreactor with external membranes.
    Jonkers C; Carrette R; De Lathouwer J; Thoeye C
    Meded Rijksuniv Gent Fak Landbouwkd Toegep Biol Wet; 2001; 66(3a):87-93. PubMed ID: 15954567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Membrane bioreactor (MBR) sludge inoculation in a hybrid process scheme concept to assist overloaded conventional activated sludge (CAS) process operations.
    Fenu A; Roels J; Van Damme S; Wambecq T; Weemaes M; Thoeye C; De Gueldre G; Van De Steene B
    Water Sci Technol; 2012; 66(2):457-63. PubMed ID: 22699354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Removal of a broad range of surfactants from municipal wastewater--comparison between membrane bioreactor and conventional activated sludge treatment.
    González S; Petrovic M; Barceló D
    Chemosphere; 2007 Feb; 67(2):335-43. PubMed ID: 17123581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biodegradation by activated sludge and toxicity of tetracycline into a semi-industrial membrane bioreactor.
    Prado N; Ochoa J; Amrane A
    Bioresour Technol; 2009 Aug; 100(15):3769-74. PubMed ID: 19162474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The application of membrane bioreactors as decentralised systems for removal of endocrine disrupting chemicals and pharmaceuticals.
    Le-Minh N; Coleman HM; Khan SJ; van Luer Y; Trang TT; Watkins G; Stuetz RM
    Water Sci Technol; 2010; 61(5):1081-8. PubMed ID: 20220228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effluent quality of a conventional activated sludge and a membrane bioreactor system treating hospital wastewater.
    Pauwels B; Fru Ngwa F; Deconinck S; Verstraete W
    Environ Technol; 2006 Apr; 27(4):395-402. PubMed ID: 16583824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Removal and fate of emerging contaminants combining biological, flocculation and membrane treatments.
    Melo-Guimarães A; Torner-Morales FJ; Durán-Álvarez JC; Jiménez-Cisneros BE
    Water Sci Technol; 2013; 67(4):877-85. PubMed ID: 23306268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation between EPS adherence, viscoelastic properties, and MBR operation: Biofouling study with QCM-D.
    Sweity A; Ying W; Ali-Shtayeh MS; Yang F; Bick A; Oron G; Herzberg M
    Water Res; 2011 Dec; 45(19):6430-40. PubMed ID: 22014563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Membrane bioreactors for water reclamation.
    Tao G; Kekre K; Wei Z; Lee TC; Viswanath B; Seah H
    Water Sci Technol; 2005; 51(6-7):431-40. PubMed ID: 16004005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of sludge structure and activity in submerged membrane bioreactor.
    Spérandio M; Masse A; Espinosa-Bouchot MC; Cabassud C
    Water Sci Technol; 2005; 52(10-11):401-8. PubMed ID: 16459815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Removal of quinolone antibiotics from wastewaters by sorption and biological degradation in laboratory-scale membrane bioreactors.
    Dorival-García N; Zafra-Gómez A; Navalón A; González J; Vílchez JL
    Sci Total Environ; 2013 Jan; 442():317-28. PubMed ID: 23178836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetic parameters for 17alpha-ethinylestradiol removal by nitrifying activated sludge developed in a membrane bioreactor.
    Clouzot L; Doumenq P; Roche N; Marrot B
    Bioresour Technol; 2010 Aug; 101(16):6425-31. PubMed ID: 20363617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of linear alkylbenzene sulfonates removal in conventional activated sludge systems and membrane bioreactors.
    De Wever H; Van Roy S; Dotremont C; Miller J; Knepper T
    Water Sci Technol; 2004; 50(5):219-25. PubMed ID: 15497851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal sludge retention time for a bench scale MBR treating municipal sewage.
    Pollice A; Laera G; Saturno D; Giordano C; Sandulli R
    Water Sci Technol; 2008; 57(3):319-22. PubMed ID: 18309207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Removal of sulfonamide antibiotics upon conventional activated sludge and advanced membrane bioreactor treatment.
    García Galán MJ; Díaz-Cruz MS; Barceló D
    Anal Bioanal Chem; 2012 Sep; 404(5):1505-15. PubMed ID: 22825676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The removal and degradation of pharmaceutical compounds during membrane bioreactor treatment.
    Schröder HF; Tambosi JL; Sena RF; Moreira RF; José HJ; Pinnekamp J
    Water Sci Technol; 2012; 65(5):833-9. PubMed ID: 22339017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Membrane bioreactors for final treatment of wastewater.
    Galil NI; Sheindorf Ch; Stahl N; Tenenbaum A; Levinsky Y
    Water Sci Technol; 2003; 48(8):103-10. PubMed ID: 14682576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.